Back to Search
Start Over
NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.
- Source :
-
Oncotarget [Oncotarget] 2017 Jan 31; Vol. 8 (5), pp. 7753-7765. - Publication Year :
- 2017
-
Abstract
- The oncogenic role of ectopic expression of Na+/H+ exchanger regulatory factor 1 (NHERF1) was recently suggested in colorectal cancer, where it was implicated in playing a role in the tumor hypoxia microenvironment. Here we showed that a high level expression of NHERF1 was found in colorectal cancer tissues and that the expression of NHERF1 was positively correlated with VEGFR2 expression. The prognostic value of VEGFR2 expression in colorectal cancer relied on the expression of NHERF1. The up-regulation of NHERF1 induced by the exposure to hypoxia in colon cancer cells depended on the activation of VEGFR2 signaling. NHERF1 in turn inhibited the activation of VEGFR2 signaling which could be regulated by the interaction between NHERF1 and VEGFR2, resulting in the reduction of migration and invasion of colon cancer cells. These results suggest a dynamic interplay between NHERF1 and VEGFR2 signaling in colorectal cancer, which could explain the contribution of NHERF1 to the regulation of tumor cell responses to the hypoxia microenvironment.
- Subjects :
- Cell Line, Tumor
Colorectal Neoplasms genetics
Colorectal Neoplasms pathology
Disease Progression
Feedback, Physiological
Humans
Neoplasm Invasiveness
Phospholipase C gamma metabolism
Phosphoproteins genetics
Proto-Oncogene Proteins c-akt
Sodium-Hydrogen Exchangers genetics
Time Factors
Tumor Hypoxia
Tumor Microenvironment
Cell Movement
Colorectal Neoplasms metabolism
Phosphoproteins metabolism
Signal Transduction
Sodium-Hydrogen Exchangers metabolism
Vascular Endothelial Growth Factor Receptor-2 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1949-2553
- Volume :
- 8
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Oncotarget
- Publication Type :
- Academic Journal
- Accession number :
- 27999191
- Full Text :
- https://doi.org/10.18632/oncotarget.13949